The Venous Care Coalition, a partnership of 10 specialty societies and associations including the American College of Radiology (ACR), recently submitted formal comments to the Agency for Healthcare Research and Quality (AHRQ) in response to its technology assessment of treatment strategies for patients with lower extremity chronic venous disease (LECVD).
Based on its own extensive review and analysis of current clinical literature, the coalition concluded the AHRQ tech assessment may have hindered interpretation of the totality of the evidence thus diminishing its ability to effectively inform policy decisions. The coalition further felt that the assessment’s exclusion of publications prior to the year 2000, focus on patient conditions without description, broad and overlapping questions, and stringent study inclusion criteria provided a subjective portrayal of the scientific evidence upon which modern LECVD treatment is based.
The Venous Care Coalition represents over 100,000 physicians who treat venous disease. Its comment letter can be reviewed in its entirety.